Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × zimberelimab × 30 days × Clear all

Sponsor

Conditions

Stomach Neoplasms 3 Carcinoma, Renal Cell 3 Kidney Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1

Interventions

avelumab 6 pembrolizumab 5 Specimen Handling 3 Nivolumab 3 Biopsy 3 Magnetic Resonance Spectroscopy 2 talimogene laherparepvec 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 deltacortene 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 aldesleukin 1 Sirolimus 1 Saline Solution 1 Radiotherapy 1 Radiosurgery 1 Prednisone 1 Lutetium-177 1 Laparoscopy 1 Ipilimumab 1 Exercise Test 1 CTLA-4 Antigen 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡